Arda is targeting cells to treat disease. We are taking aim at chronic diseases and aging by eliminating the pathogenic cells that drive these conditions.
A new approach to old diseases
Cells are the functional units of life, but they are also the functional units of disease. Many diseases are caused by certain cell populations becoming too abundant or active; for example, the overgrowth of stromal cell types contributes to fibrosis, while the excessive activation of particular immune cells leads to chronic inflammation. Arda’s hypothesis is that removing these cells will delay or reverse disease progression.
Our approach starts by using single-cell data to identify pathogenic cells and specific markers to target them. We then design therapies to eliminate these - and only these - cells. We are initially focused on treating chronic diseases, with the long-term goal of extending healthy lifespan.
Arda is a seed-stage biotech located in the San Francisco Bay Area. We are backed by Andreessen Horowitz, GV, The Longevity Fund, Village Global, Axial, NJF and others. Our mission is clear, our commitment is strong, and our expectations are high. Come build with us.
What we value
Rigor. Decisions are based on data. Persuasive arguments are built from evidence and logic, not from authority or wishful thinking. Truth is paramount.
Impact. We measure outputs, not inputs. We think carefully about where to put our goalposts, and once placed, we drive toward them with zeal. Value comes from contribution, not credentials.
Community. Whether we succeed or fail, we do so as a team. We communicate with transparency and speak to one another with respect. We reject hypotheses, not people.
Accountability. To our patients and to each other. We are each responsible for our words, actions, and results.
Grit. Doing science means being wrong, a lot. We strive for progress, not perfection. We persevere. We build skill and knowledge through consistent and deliberate effort.
As a Scientist in the Biologics group, you will drive the discovery, engineering, and validation of antibodies against various targets to advance Arda’s drug discovery programs. This is an opportunity to shape the company from the very beginning: your input will be essential to Arda's strategy, process, and culture. The experience you gain in this role is a rare commodity that will establish you as an operator and builder.
Beyond exciting science, you’ll have enough equity to be a true stakeholder in the company, a competitive salary and benefits, an unlimited vacation policy so you can be at your best while you’re working, remote work flexibility, and enthusiastic support from the other members of our inclusive, world-class team.
In this role, you will:
Support the therapeutic strategy of Arda by generating and characterizing antibodies against various targets
Independently design, plan and execute experiments to advance therapeutic antibody candidates
Engineer, express and purify recombinant proteins from mammalian cells
Use various assays and techniques to characterize biochemical and biophysical properties of antibodies and recombinant proteins (e.g. binding, stability, aggregation, etc.)
Manage external resources to discover novel binders against validated targets
You have earned a Ph.D. in biological sciences or a related discipline
Your substantial wet lab experience includes many of the techniques and tools listed above. Experience working in biologics drug discovery in an industry setting is a big plus.
You have deep technical expertise in antibody biology, engineering, expression, and purification
You have extensive hands-on experience with protein characterization using SDS-PAGE, HPLC, ELISA, BLI and/or SPR
Experience with molecular cloning (PCR, Gibson assembly, plasmid preparation) is a plus
Experience working with novel modalities (e.g. bispecifics, multispecifics, fusion proteins, immune cell engagers or ADCs) is a plus